Zynex, Inc. (ZYXI) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1163171,
    "name": "Zynex, Inc.",
    "stock_name": "Zynex, Inc.",
    "full_name": "Zynex, Inc.",
    "name_url": "stocks-analysis/zynex-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.03",
    "chg": -0.14,
    "chgp": "-11.97%",
    "dir": -1,
    "prev_price": "1.17",
    "mcapval": "46.05",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US98986M1036",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "2.32 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zynex-inc-1163171-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Zynex, Inc. Stock Plummets to New 52-Week Low at $1.03",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zynex-inc-stock-plummets-to-new-52-week-low-at-103-3686419",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ZynexInc_priceRelatedfactors_3686419.png",
        "date": "2025-11-10 17:07:21",
        "description": "Zynex, Inc. has hit a new 52-week low, experiencing a significant decline in stock price over the past year. The company faces ongoing financial challenges, including substantial losses and negative cash flow. With a market capitalization of USD 46 million, Zynex's performance has consistently lagged behind broader market trends."
      },
      {
        "title": "Zynex, Inc. Stock Plummets to New 52-Week Low of $1.05",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zynex-inc-stock-plummets-to-new-52-week-low-of-105-3680148",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ZynexInc_priceRelatedfactors_3680148.png",
        "date": "2025-11-07 16:00:40",
        "description": "Zynex, Inc. has hit a new 52-week low, reflecting significant challenges as it faces an 88.91% stock price decline over the past year. The company has reported nine consecutive quarters of negative results, with substantial losses and a high debt-to-equity ratio, raising concerns about its financial stability."
      },
      {
        "title": "Zynex, Inc. Stock Plummets to New 52-Week Low at $1.13",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zynex-inc-stock-plummets-to-new-52-week-low-at-113-3667274",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ZynexInc_priceRelatedfactors_3667274.png",
        "date": "2025-11-03 17:05:03",
        "description": "Zynex, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low, reflecting a significant decline in stock performance over the past year. The company has reported negative financial results for nine consecutive quarters, indicating ongoing challenges in its operations and market position."
      },
      {
        "title": "Zynex, Inc. Stock Plummets to New 52-Week Low of $1.22",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zynex-inc-stock-plummets-to-new-52-week-low-of-122-3661922",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ZynexInc_priceRelatedfactors_3661922.png",
        "date": "2025-10-31 16:08:57",
        "description": "Zynex, Inc. has hit a new 52-week low, reflecting a challenging year marked by an 86.8% decline in stock price. The company faces significant financial difficulties, including a pre-tax profit loss and negative operating cash flow, alongside a high debt-to-equity ratio and negative return on equity."
      },
      {
        "title": "Is Zynex, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-zynex-inc-technically-bullish-or-bearish-3547156",
        "imagepath": "",
        "date": "2025-09-20 19:48:21",
        "description": "As of 1 August 2025, the technical trend for Zynex, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the daily moving averages and the weekly KST being bearish. The MACD shows a mildly bullish signal on the weekly timeframe but is bearish on the monthly, which adds to the mixed signals. The Bollinger Bands and OBV are also indicating bearish trends. \n\nIn terms of performance, Zynex has significantly underperformed compared to the S&P 500, with a year-to-date return of -80.65% versus the S&P 500's 12.22%, and a one-year return of -81.05% compared to 17.14% for the index...."
      },
      {
        "title": "Is Zynex, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-zynex-inc-overvalued-or-undervalued-3543581",
        "imagepath": "",
        "date": "2025-09-20 18:23:19",
        "description": "As of 29 April 2025, the valuation grade for Zynex, Inc. has moved from expensive to risky, indicating a deterioration in its perceived value. The company appears to be overvalued given its negative financial metrics, with a Price to Book Value of 3.30, an EV to EBIT of -14.15, and an EV to Sales ratio of 0.63. In comparison, peers such as CareDx, Inc. have a very attractive valuation with a P/E of -27.9089, while Organogenesis Holdings, Inc. is also risky with a P/E of 608.5864, highlighting Zynex's struggles within its industry.\n\nThe stock has significantly underperformed against the S&P 500, with a year-to-date return of -80.65% compared to the index's 12.22%. This stark contrast reinforces the notion that Zynex is currently overvalued, as its financial performance does not support its market price...."
      }
    ],
    "total": 11,
    "sid": "1163171",
    "stock_news_url": "https://www.marketsmojo.com/news/zynex-inc-1163171"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Zynex, Inc. Stock Plummets to New 52-Week Low at $1.03

2025-11-10 17:07:21

Zynex, Inc. has hit a new 52-week low, experiencing a significant decline in stock price over the past year. The company faces ongoing financial challenges, including substantial losses and negative cash flow. With a market capitalization of USD 46 million, Zynex's performance has consistently lagged behind broader market trends.

Zynex, Inc. Stock Plummets to New 52-Week Low of $1.05

2025-11-07 16:00:40

Zynex, Inc. has hit a new 52-week low, reflecting significant challenges as it faces an 88.91% stock price decline over the past year. The company has reported nine consecutive quarters of negative results, with substantial losses and a high debt-to-equity ratio, raising concerns about its financial stability.

Zynex, Inc. Stock Plummets to New 52-Week Low at $1.13

2025-11-03 17:05:03

Zynex, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low, reflecting a significant decline in stock performance over the past year. The company has reported negative financial results for nine consecutive quarters, indicating ongoing challenges in its operations and market position.

Zynex, Inc. Stock Plummets to New 52-Week Low of $1.22

2025-10-31 16:08:57

Zynex, Inc. has hit a new 52-week low, reflecting a challenging year marked by an 86.8% decline in stock price. The company faces significant financial difficulties, including a pre-tax profit loss and negative operating cash flow, alongside a high debt-to-equity ratio and negative return on equity.

Is Zynex, Inc. technically bullish or bearish?

2025-09-20 19:48:21

As of 1 August 2025, the technical trend for Zynex, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the daily moving averages and the weekly KST being bearish. The MACD shows a mildly bullish signal on the weekly timeframe but is bearish on the monthly, which adds to the mixed signals. The Bollinger Bands and OBV are also indicating bearish trends. In terms of performance, Zynex has significantly underperformed compared to the S&P 500, with a year-to-date return of -80.65% versus the S&P 500's 12.22%, and a one-year return of -81.05% compared to 17.14% for the index....

Is Zynex, Inc. overvalued or undervalued?

2025-09-20 18:23:19

As of 29 April 2025, the valuation grade for Zynex, Inc. has moved from expensive to risky, indicating a deterioration in its perceived value. The company appears to be overvalued given its negative financial metrics, with a Price to Book Value of 3.30, an EV to EBIT of -14.15, and an EV to Sales ratio of 0.63. In comparison, peers such as CareDx, Inc. have a very attractive valuation with a P/E of -27.9089, while Organogenesis Holdings, Inc. is also risky with a P/E of 608.5864, highlighting Zynex's struggles within its industry. The stock has significantly underperformed against the S&P 500, with a year-to-date return of -80.65% compared to the index's 12.22%. This stark contrast reinforces the notion that Zynex is currently overvalued, as its financial performance does not support its market price....

View All News